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Diagnostic dilemmaAbstract Cutaneous Leishmaniasis (CL) is a disease caused by an intracellular protozoa belong to
the genus Leishmania, transmitted by the bite of a sandfly. It has diverse clinical presentation and
may create a public health problem in endemic countries. CL is often confused with lepromatous
leprosy, pimples and fungal dermatitis. This case is an isolated cutaneous variety in facial region
which was mistaken and treated initially for fungal dermatitis and then for leprosy by local physi-
cians. Smears examined from the skin lesion confirmed Leishmania amastigotes. The isolated local-
ized CL may create confusion and its many differential diagnoses made delaying in the diagnosis.
 2015 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Leishmaniasis is a vector borne disease and caused by a kine-
toplastid protozoan parasite. The parasite is transmitted from
one patient to another through the bites of female sandfly, or
occasionally through non-vector routes including congenital,
blood transfusion, sexual, laboratory acquired and person-to-person.1 Leishmaniasis can be divided into three forms
varying in severity from spontaneously healing dermatological
ulcers in Cutaneous leishmaniasis (CL) and destructive form of
mucocutaneous leishmaniasis to fatal form of visceral leishma-
niasis (VL). CL is seen throughout Africa, South America,
Asia, the Middle East, and the Mediterranean regions. It has
diverse clinical manifestations, which poses a public health
problem in endemic countries.2 This disease can affect the skin,
viscera or mucocutaneous area. Often CL cases are mistaken
for common dermatological disorders such as fungal infec-
tions, bacterial infections, eczema or chronic ulcers that may
delay in diagnosis and treatment. In some cases, patients con-
sult several doctors before CL diagnosis. This situation leads
to delay in the exact diagnosis and inadvertent exposure to
344 S.K. Swain et al.adverse events of inappropriate treatment. Here an isolated
lesion over the face made a misdiagnosis for fungal dermatitis
initially and then leprosy by local physicians for which patient
had taken prolonged unnecessary treatment due to delay in
diagnosis.
2. Case report
A 48 year old male from northeast part of India presented to
Outpatient department of Otorhinolaryngology for non-
healing skin lesions over the face (Fig. 1A and B). From his-
tory, it was found that he was treated by many physicians by
multiple drugs since two years, initially for fungal dermatitis
and then for leprosy but lesions were not healed. On examina-
tion there are several small painless papular lesions with
indurations. The papular lesions are showing central ulcera-
tion with erythematous borders over the forehead and cheek.
He had no significant medical history and patient was in good
health. He had no history of fever, lymphadenopathy, hep-
atosplenomegaly or weight loss which are typical of VL. There
were no signs of neuropathy. General clinical examinations
and routine blood investigations were within normal limit.
HIV test was negative. Slit skin smears from facial lesions were
stained with Ziehel-Nielsen stain and revealed negative for
acid-fast bacilli.
The biopsies and smears were taken from the facial lesions
under the local anaesthesia and sent for histopathological
examination. Light microscopy revealed skin with hyperker-
atosis, acanthosis and parakeratosis. The dermis was invaded
with large pink coloured histiocytes and chronic inflammatory
cells. The histiocytes contained inside dot-like organisms typi-
cal of cutaneous leishmania (Fig. 2). He was treated with
sodium stibogluconate for 3 weeks (intramuscular 20 mg/kg
daily for 3 weeks). The cutaneous lesions of the face disap-
peared and there has been no evidence of recurrence after
two years.
3. Discussion
Leishmaniasis is caused by unicellular, flagellate, intracellular
protozoa belonging to the genus Leishmania transmitted fromFigure 1 Cutaneous leishmaniasis lesions seen oveanimals to humans through phlebotomine sandfly vectors.
Common species of Leishmania responsible for CL in old
world are L. major and L. tropica whereas L. mexicana, L.
panamenesis and L. braziliensis in new world. The geographical
distribution of Leishmaniasis is confined to temperate and
tropical countries, the living area of the sandfly. Ninety per-
centages of cases of CL occur in Brazil, Afghanistan, Iran,
Algeria, Peru, and Syria whereas visceral leishmaniasis is
found in Bangladesh, India, Brazil, Nepal and Sudan.3 In
India, indigenous cases of CL are mainly confined to hot dry
northwestern region and are endemic in the western Thar
desert of Rajasthan.4 Few cases have been observed in the
states such as Kerala, Assam and Haryana.5 Apart from this
it was documented in northwestern part of Indo-Gangetic
plain, along with dry areas of Indo-Pakistan border from
Amritsar to Gujarat.6 In southern part of India, CL has been
reported from Malappuram and Trivandrum of Kerala.7 The
CL is usually caused by L. tropica and man is the most com-
mon reservoir in India.
Leishmaniasis has been considered tropical afflictions and
constitutes one of the six entities in the World health organiza-
tion/Tropical disease research (WHO/TDR) list of the most
important diseases.8,9 Leishmaniasis is endemic in 88 countries
of the five continents with total of 350 million people at risk
and heaves 12 million cases. Out of the 88 endemic countries,
22 are in the New World and 66 in the Old World with an esti-
mated incidence of 1–1.5 million cases of CL and 5 lakhs cases
of visceral leishmaniasis (VL).9 Even it has widespread geo-
graphical distribution, human leishmaniasis is often very focal
within an endemic region, leading to ‘hotspots’ of the disease
transmission.5 Localized cutaneous lesions of leishmaniasis
may resemble to other skin conditions such as lepromatous
leprosy, cutaneous anthrax, blastomycosis, sporotrichosis,
eczema, fungal skin infections, Mycobacterium marinum infec-
tions, sarcoidosis and infected insect bites. Isolated cutaneous
lesion of leishmaniasis over the face may mimic lupus vulgaris,
chronic discoid erythematosus, cutaneous lymphoma and
erysipelas.10,11 Infections by Leishmania are increasing world-
wide due to tourism and job related travel and refugees.12
The parasite multiplies inside the macrophages and other
types of reticuloendothelial cells will rupture and release ther the face (A) frontal view and (B) lateral view.
Figure 2 Giemsa staining from the skin lesion showing numerous histiocytes laden with multiple leishman parasites. (Giemsa, original
magnification  1000).
Isolated cutaneous leishmaniasis over face 345organism into the blood stream. If the female sandfly bites an
infected host, the amastigotes enter the sandfly and develop
into infective promastigotes. This cycle is completed when
the vector bites another host.
Common techniques used for diagnosis of leishmaniasis
including CL and VL are (i) demonstration of parasites in tis-
sues by light microscopic examination of stained specimen,
in vitro or in vivo; (ii) immunodiagnosis by detection of para-
site antigen in tissue, blood or urine samples by detection of
antileishmanial antibodies or by assay for Leishmania-
specific cell-mediated immunity or (iii) detection of parasites
DNA in tissue samples.13
Patients presenting with non-healing papular lesions need
smear from the depth of the lesions after that staining with
Giemsa or hematoxylin–eosin and identification of the parasite
or Donovan bodies via light microscope.
CL lesion may heal spontaneously, with scarring or evolv-
ing into diffuse pattern of CL, with decreased immune
response.14 CL usually presents with painless nodules with a
characteristic erythematous raised border similar to pimples.
The lesions healed over months to years leaving with a scar.
The causative species of CL decides the clinical presentation,
course and treatment. Intralesional or systemic antimonials
are the gold standard for the treatment.
After correct diagnosis of CL, the choice drug for treatment
is important aspect as commonly used anti-leishmanial drugs
such as antimony medications are often not enough as single
therapy. It may cause a prolonged course of disease and give
rise to undesirable side effects of antimony drugs and may
be associated with disfiguring cutaneous scars. Confirmed
CL diagnosis the combination regime should be used as first-
line therapy to prevent prolonged exposure to single antimony
therapy which may cause non-healing and resistant cases of
CL. The combination therapy using recommended doses of
allopurinol and antimony drugs shortens the duration of treat-
ment. Combination therapy has been used successfully in resis-
tant cases of VL.15 Local treatment is carried out instead of
systemic treatment if there is no risk for mucocutaneous leish-
maniasis. Local treatment may be useful as an adjuvant to sys-
temic treatment for accelerating the healing process. Topicalointment containing 15% paromomycin and 12% methylben-
zethonium chloride was applied twice daily for 20 days. Paro-
momycin ointments are helpful in L. major, L. tropica, L.
mexicana and L. panamensis. In case of L. braziliensis localized
type of lesion, both paromomycin and imiquimod may be
locally applied. Oral zinc sulphate and fluconazole are useful
in L. major. Intramuscular pentamidine is required for L.
guyanen CL, for which systemic antimony is not effective.16
After developing Pentavalent antimonials, it remains first-
choice treatment for both visceral and cutaneous leishmaniasis
in most parts of the world. The Amphotericin B and pen-
tamidine are the second-line antileishmanial drugs, although
they require long courses of parenteral administration.17 Bas-
ing upon the causative of leishmania species the choice of
treatment is decided by the clinicians.7 Although spontaneous
cure is the rule, the rate of recovery varies depending on the
species of causative agents, and may require months or years
to complete healing.18
Imidazoles are potential therapeutic agents in cutaneous
leishmaniasis. They act by interfering with the synthesis of
ergosterol that is present in the cell wall of Leishmania spp.
The efficacy of ketoconazole in different doses for variable
periods in cutaneous leishmaniasis has been documented.19
Most of the commonly used drugs are toxic and do not cure,
i.e., eliminate the parasite, from infected individuals. Failure
to treat leishmaniasis successfully is often due to increased
chemo-resistance of the parasite. Recently, microspheres of
hydrophilic albumin with three amphotericin B aggregation
states (monomeric, dimeric, and multiaggregate) and a ultiag-
gregate form encapsulated with two commercial polymers were
tested against Leishmania infantum (both extracellular pro-
mastigote and intracellular amastigote forms). The albumin-
encapsulated forms showed no toxicity. These amphotericin
B encapsulated in microspheres are exploring new chemother-
apeutic approaches.20
4. Conclusion
Leishmaniasis is an infection caused by the protozoa Leishma-
nia, transmitted by the sandfly. An isolated lesion over the face
346 S.K. Swain et al.may form at the site of insect bite. These lesions are many
times mistaken for leprosy, fungal dermatitis or facial pimples.
Smears and histopathological examination should be done
early for any lesion presenting more than two weeks under
local anaesthesia and sent for examination to ensure the diag-
nosis and treatment.
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